COAFIBRA Trademark

Trademark Overview

On Thursday, December 24, 2009, a trademark application was filed for COAFIBRA with the United States Patent and Trademark Office. The USPTO has given the COAFIBRA trademark a serial number of 79078846. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, December 25, 2019. This trademark is owned by FOURNIER INDUSTRIE ET SANTE. The COAFIBRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention and treatment of cardio-vascular diseases and associated diseases; pharmaceutical preparations for the cardio-vascular system
coafibra

General Information

Serial Number79078846
Word MarkCOAFIBRA
Filing DateThursday, December 24, 2009
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, December 25, 2019
Registration Number3828578
Registration DateTuesday, August 3, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 18, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the prevention and treatment of cardio-vascular diseases and associated diseases; pharmaceutical preparations for the cardio-vascular system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 10, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbott Products Distribution SAS
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameFOURNIER INDUSTRIE ET SANTE
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressF-21000 Dijon
FR
Party NameFOURNIER INDUSTRIE ET SANTE
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressF-21000 Dijon
FR

Trademark Events

Event DateEvent Description
Friday, August 28, 2020NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, August 28, 2020DEATH OF INTERNATIONAL REGISTRATION
Thursday, October 18, 2018NEW REPRESENTATIVE AT IB RECEIVED
Friday, December 29, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, November 14, 2017TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, November 14, 2017INVALIDATION PROCESSED
Friday, November 10, 2017TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, March 10, 2017CANCELLED SECTION 71
Thursday, January 5, 2017NEW REPRESENTATIVE AT IB RECEIVED
Friday, December 4, 2015CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, August 3, 2015COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, January 29, 2015CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, November 27, 2014NEW REPRESENTATIVE AT IB RECEIVED
Friday, April 26, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 26, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, February 10, 2013NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, September 11, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 11, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 3, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, May 18, 2010PUBLISHED FOR OPPOSITION
Wednesday, April 28, 2010NOTICE OF PUBLICATION
Wednesday, April 14, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 14, 2010ASSIGNED TO LIE
Friday, March 26, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 24, 2010ASSIGNED TO EXAMINER
Tuesday, March 2, 2010APPLICATION FILING RECEIPT MAILED
Friday, February 26, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 25, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

coafibra pharmaceutical diseases vascular preparations cardio associated system treatment substances prevention